We are exploring whether infusions of a cell-derived product can improve heart function in patients with non-ischemic dilated cardiomyopathy. This study aims to find new treatment options for this condition.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-ischemic Dilated Cardiomyopathy (DCM) is a condition where the heart becomes enlarged and weakened, affecting its ability to pump blood effectively. This can lead to symptoms such as fatigue, shortness of breath, and swelling in the legs and ankles.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.